4.2 Daytime Sleep Testing Protocols: MSLT & MWT

4.2 Daytime Sleep Testing Protocols: MSLT & MWT

Daytime neurophysiological sleep testing provides objective quantification of daytime sleepiness and the ability to maintain alertness. For the Certified Polysomnographic Technician (CPSGT), mastering the rigid execution protocols of the Multiple Sleep Latency Test (MSLT) and the Maintenance of Wakefulness Test (MWT) is critical. These standardized daytime procedures adhere to exacting timing intervals, termination rules, and pre-test medication and sleep hygiene criteria.

---

1. Multiple Sleep Latency Test (MSLT) Overview & Pre-Test Standardization

The MSLT is the validated gold standard for measuring objective physiological sleep propensity in a sleep-inducing environment and identifying abnormal rapid transitions from wakefulness into REM sleep (Sleep-Onset REM Periods / SOREMPs).

+-----------------------------------------------------------------------------+
|                     MANDATORY MSLT PRE-TEST PREREQUISITES                   |
|                                                                             |
|   [1] SLEEP DIARY / ACTIGRAPHY:  1 to 2 weeks of documented sleep logs     |
|                                  verifying regular sleep schedule (>=7h/nt) |
|   [2] MEDICATION WITHDRAWAL:     Discontinue REM-suppressing drugs (SSRIs,  |
|                                  SNRIs, TCAs, stimulants) >= 2 weeks prior  |
|                                  (3 to 4 weeks for fluoxetine) under MD OK  |
|   [3] PRECEDING NIGHT PSG:       Mandatory full-night diagnostic PSG        |
|                                  Must document >= 6.0 hours (360 min) TST   |
|   [4] URINE DRUG SCREEN (UDS):   Collected on test morning before Nap 1     |
|   [5] STIMULANT RESTRICTION:     No caffeine, tobacco/nicotine (>=30 min),  |
|                                  or strenuous exercise on testing day       |
+-----------------------------------------------------------------------------+

Clinical Rationale for Preceding PSG & Drug Screening:

• Ruling Out Sleep Deprivation: Acute sleep restriction causes pathological daytime sleepiness and can trigger false-positive SOREMPs in normal individuals. If the preceding overnight PSG demonstrates $< 6.0\text{ hours}$ of Total Sleep Time (TST), the MSLT must be postponed or rescheduled.
• Ruling Out Untreated Sleep Apnea: Severe OSA causes sleep fragmentation and severe daytime sleepiness, producing artifactual MSLT abnormalities.
• Urine Drug Screen (UDS): Collected immediately following the overnight PSG to ensure that findings are not confounded by unprescribed sedatives, illicit substances (cannabinoids, amphetamines), or secretly continued REM-suppressing antidepressants.

---

2. Standard MSLT Nap Scheduling & Execution Protocol

The standard MSLT protocol consists of 4 or 5 nap opportunities administered at exact 2-hour intervals.

+-----------------------------------------------------------------------------+
|                        MSLT 5-NAP SCHEDULE TIMELINE                         |
|                                                                             |
|   06:00 - 06:30 ---> Preceding Overnight PSG Lights On / Wake-up            |
|   06:30 - 07:15 ---> Morning Urine Drug Screen & Light Breakfast (No Cafe)  |
|   08:30 - 09:00 ---> NAP 1 (1.5 to 3.0 hours post-PSG awakening)            |
|   10:30 - 11:00 ---> NAP 2 (2 hours after Nap 1 start)                      |
|   11:30 - 12:15 ---> Light Lunch (No Caffeine)                              |
|   12:30 - 13:00 ---> NAP 3 (2 hours after Nap 2 start)                      |
|   14:30 - 15:00 ---> NAP 4 (2 hours after Nap 3 start)                      |
|   16:30 - 17:00 ---> NAP 5 (Optional 5th nap if exactly 1 SOREMP in Naps 1-4)|
+-----------------------------------------------------------------------------+

In-Nap Procedure & Termination Rules:

For each nap opportunity, the patient is prepped in bed in a dark, quiet, temperature-controlled room. The technician conducts pre-nap biocalibrations and instructs: "Please lie quietly, close your eyes, and try to fall asleep."

+-----------------------------------------------------------------------------+
|                        MSLT NAP TRIAL TERMINATION RULES                     |
|                                                                             |
|   SCENARIO A: NO SLEEP OCCURS WITHIN 20 MINUTES                               |
|   - If no sleep is scored after 20 minutes from Lights Out:                 |
|     --> Terminate the trial at exactly 20 minutes.                          |
|     --> Score Sleep Latency = 20.0 minutes.                                 |
|     --> Score SOREMP = None (0).                                            |
|                                                                             |
|   SCENARIO B: SLEEP ONSET OCCURS WITHIN 20 MINUTES                          |
|   - Sleep onset = The first 30-second epoch scored as ANY sleep stage        |
|     (Stage N1, N2, N3, or Stage REM; even 1 epoch of N1 counts!).           |
|   - Score Sleep Latency = Elapsed time from Lights Out to first sleep epoch.|
|   - MANDATORY RULE: Continue recording for EXACTLY 15 MINUTES from the      |
|     start of the first epoch of sleep, regardless of waking/arousals.       |
|   - Evaluate the 15-minute window for the occurrence of Stage REM sleep.    |
|   - Terminate trial at exactly 15 minutes post-sleep onset.                 |
+-----------------------------------------------------------------------------+

[!IMPORTANT] The 15-Minute Post-Sleep Onset Rule: Technicians must never stop an MSLT nap trial immediately after sleep onset. You must record for exactly 15 minutes from the first epoch of sleep to determine whether the patient enters REM sleep (a SOREMP). Terminating early prevents REM detection and invalidates the test.

---

3. MSLT Scoring Calculations & Diagnostic Criteria

Mean Sleep Latency (MSL) Formula:

Sleep latency is recorded in minutes for each nap. If no sleep occurs, that nap is assigned a latency of 20.0 minutes.

$\text{Mean Sleep Latency (MSL)} = \frac{\text{Sleep Latency Nap 1} + \text{Nap 2} + \text{Nap 3} + \text{Nap 4} \ (+ \text{Nap 5})}{\text{Total Number of Naps Conducted (4 or 5)}}$

SOREMP Scoring Rule:

• SOREMP (Sleep-Onset REM Period): Defined as the occurrence of at least one 30-second epoch of Stage REM sleep occurring within 15 minutes of sleep onset on an MSLT nap opportunity.
• Overnight PSG SOREMP Rule: Under the International Classification of Sleep Disorders (ICSD-3), a SOREMP occurring on the diagnostic overnight PSG immediately preceding the MSLT (defined as REM onset within 15 minutes of sleep onset) counts as one of the required SOREMPs for diagnosing narcolepsy.

ICSD-3 Diagnostic Differentiation:

CONCRETE MSLT CALCULATION WORKBOOK:
A 24-year-old patient undergoes a 5-nap MSLT following an overnight PSG with 410 min TST (no REM on PSG):
- Nap 1: Sleep onset at 3.0 min; Stage REM at min 7.0 (SOREMP present). Trial ended at min 18.0.
- Nap 2: Sleep onset at 1.5 min; Stage N2 throughout; no REM. Trial ended at min 16.5.
- Nap 3: Sleep onset at 4.5 min; Stage REM at min 9.0 (SOREMP present). Trial ended at min 19.5.
- Nap 4: Sleep onset at 2.0 min; Stage N1/N2; no REM. Trial ended at min 17.0.
- Nap 5: Sleep onset at 4.0 min; Stage N1/N2; no REM. Trial ended at min 19.0.

Calculations:
1. Sum of Sleep Latencies = 3.0 + 1.5 + 4.5 + 2.0 + 4.0 = 15.0 minutes
2. Mean Sleep Latency (MSL) = 15.0 / 5 = 3.0 minutes (Pathological hypersomnolence <= 8.0 min)
3. Total SOREMPs = 2 (Nap 1 and Nap 3)
--> CONCLUSION: Findings meet ICSD-3 criteria for Narcolepsy (MSL <= 8.0 min and >= 2 SOREMPs).

---

4. Maintenance of Wakefulness Test (MWT) Protocol

While the MSLT evaluates the propensity to fall asleep in a sleep-promoting setting, the Maintenance of Wakefulness Test (MWT) assesses an individual's objective ability to remain awake in a quiet, non-stimulating environment.

+-----------------------------------------------------------------------------+
|                 MAINTENANCE OF WAKEFULNESS TEST (MWT) PROTOCOL              |
|                                                                             |
|   STRUCTURE:        Four 40-minute trials conducted at 2-hour intervals     |
|                     Starting 1.5 to 3.0 hours after morning awakening       |
|                                                                             |
|   PATIENT POSTURE:  Seated fully upright in a comfortable armchair/recliner |
|                     with head and back support (NOT in bed)                 |
|                                                                             |
|   LIGHTING & ROOM:  Dim illumination (0.10 to 0.13 lux / ~1.0 foot-candle)  |
|                     measured at eye level; quiet acoustic isolation         |
|                                                                             |
|   INSTRUCTIONS:     "Please sit still, look straight ahead, and try to stay |
|                     awake for as long as you can. Do not engage in repetitive|
|                     movements, singing, tapping, or eye-rubbing."           |
+-----------------------------------------------------------------------------+

MWT Trial Termination Criteria:

A 40-minute MWT trial is terminated upon the occurrence of either of the following conditions:

1. Full 40 Minutes Completed: If no sleep occurs, the trial is terminated at 40 minutes, and sleep latency is scored as 40.0 minutes.
2. Definitive Sleep Criteria Met: The trial must be terminated immediately upon recording:
   • Three consecutive 30-second epochs of Stage N1 sleep, OR
   • One single 30-second epoch of any other sleep stage (Stage N2, N3, or Stage REM).

Occupational Safety & Clinical Utility:

• Target Populations: Commercial truck and motorcoach drivers (DOT), airline pilots (FAA), locomotive engineers, maritime navigators, and patients treated for severe OSA or narcolepsy requesting driving privilege reinstatement.
• Normative Standards:
  • Normal mean sleep latency on the 40-minute MWT is 30.4 to 40.0 minutes.
  • A mean sleep latency $< 8.0\text{ minutes}$ indicates pathological inability to maintain wakefulness, representing severe public safety risk.
  • Federal safety standards (e.g., FAA) typically mandate a mean sleep latency $> 33\text{ minutes}$ (or complete absence of sleep across all four trials) for medical recertification.